This list is based on the watchlists of people on Stock Events who follow 6589.TW. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
EirGenix Inc. operates as a contract development and manufacturing company in Taiwan and internationally. The company offers cell line development, process development, analytical and quality control, cGMP manufacturing mammalian and microbial system, and antibody-drug conjugate services. It is also involved in the development of EG12014/EGI014, a Trastuzumab biosimilar, indicated for the treatment of cancer and currently under biologics license application status; EG1206A, a Pertuzumab biosimilar, indicated for the treatment of cancer and currently under Phase I stage; EG13074, indicated for the treatment of cancer and currently under Preclinical stage; TSY0110(EG12043), an antibody-drug conjugate, indicated for the treatment of cancer and currently under Preclinical stage; EG12021, Bevacizumab biosimilar, indicated for the treatment of cancer and currently under Preclinical stage; and EG62054, a biosimilar, currently under Preclinical stage. In addition, the company manufactures and sells covid-19 antigen rapid test; and EG74032, a CRM197 carrier protein. The company was incorporated in 2012 and is headquartered in New Taipei City, Taiwan.
The current price of 6589.TW is TWD49.85 TWD — it has decreased by -1.48% in the past 24 hours. Watch EirGenix stock price performance more closely on the chart.
What is EirGenix stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange EirGenix stocks are traded under the ticker 6589.TW.
What is EirGenix market cap?▼
Today EirGenix has the market capitalization of 15.26B
When is the next EirGenix earnings date?▼
EirGenix is going to release the next earnings report on May 19, 2026.
What is EirGenix revenue for the last year?▼
EirGenix revenue for the last year amounts to 2.02B TWD.
What is EirGenix net income for the last year?▼
6589.TW net income for the last year is -1.4B TWD.
In which sector is EirGenix located?▼
EirGenix operates in the Other sector.
When did EirGenix complete a stock split?▼
EirGenix has not had any recent stock splits.
Where is EirGenix headquartered?▼
EirGenix is headquartered in New Taipei City, Taiwan.